Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?

Am J Respir Crit Care Med. 2020 Feb 15;201(4):405-406. doi: 10.1164/rccm.201911-2160ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Isoniazid
  • Latent Tuberculosis*
  • Macaca
  • Mycobacterium tuberculosis*
  • Rifampin / analogs & derivatives

Substances

  • Isoniazid
  • Rifampin
  • rifapentine